Á lódáil...
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses
Experimental monoclonal antibody (mAb) therapies have shown promise for treatment of lethal Ebola virus (EBOV) infections, but their species-specific recognition of the viral glycoprotein (GP) has limited their use against other divergent ebolaviruses associated with human disease. Here, we mined th...
Na minha lista:
Foilsithe in: | Cell |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
2017
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808922/ https://ncbi.nlm.nih.gov/pubmed/28525755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2017.04.037 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|